Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:gilead_sciences [2022/01/18 10:09] liam [Remdesivir] | pharmaceutical_companies:gilead_sciences [2022/01/18 10:14] (current) liam [Affiliations] |
---|
| |
Gilead is the developer of remdesivir, the only "[[:Food and Drug Administration|FDA]]-approved [[:COVID-19]] treatment".((COVID-19 Treatment Guidelines Panel. //Remdesivir.// COVID-19 Treatment Guidelines. Retrieved December 6, 2021, from https://archive.ph/Pfu6f)) | Gilead is the developer of remdesivir, the only "[[:Food and Drug Administration|FDA]]-approved [[:COVID-19]] treatment".((COVID-19 Treatment Guidelines Panel. //Remdesivir.// COVID-19 Treatment Guidelines. Retrieved December 6, 2021, from https://archive.ph/Pfu6f)) |
===== Lobbying ===== | |
| ===== Affiliations ===== |
| |
| Part of the [[:COVID-19 Therapeutics Accelerator]] funded by the [[:Bill & Melinda Gates Foundation]], [[:Wellcome Trust]], and [[:Mastercard]] to “accelerate treatments, [[:vaccines]], and diagnostics”.((//Global pharma industry unites behind COVID-19 Therapeutics Accelerator.// (2020, March 26). The Pharma Letter. https://archive.ph/yS7v2)) |
| ==== Lobbying ==== |
| |
https://www.thegatewaypundit.com/2020/05/first-case-covid-19-us-treated-remdesivir-late-january-two-weeks-later-china-mass-producing-drug-firm-gilead-sciences-dr-fauci-middle/?fbclid=IwAR0UKDGqzXywE27oROwUn29PMd8EZgdjjKD6n_vC_yYmfkLV9kW07OCNycs | https://www.thegatewaypundit.com/2020/05/first-case-covid-19-us-treated-remdesivir-late-january-two-weeks-later-china-mass-producing-drug-firm-gilead-sciences-dr-fauci-middle/?fbclid=IwAR0UKDGqzXywE27oROwUn29PMd8EZgdjjKD6n_vC_yYmfkLV9kW07OCNycs |